Impact of race on treatment and survival among U.S. veterans with early-stage lung cancer

Journal of Thoracic Oncology

Volumn 11, Issue 10, 2016, Pages 1672-1681

  Williams, Christina D ^a,b   Salama, Joseph K ^b   Moghanaki, Drew ^c,d   Karas, Tomer Z ^e   Kelley, Michael J ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e Research Service Bruce Carter Memorial Veterans Health Administration Medical Center   (United States)

Author keywords

Early stage; Lung cancer; Racial disparity; Survival; Treatment

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; DISEASE SEVERITY; EARLY CANCER; EUROPEAN AMERICAN; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED STATES; VETERAN; ANCESTRY GROUP; CANCER STAGING; COHORT ANALYSIS; ETHNOLOGY; FEMALE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; SURVIVAL RATE;

AGED; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; VETERANS;

EID: 84991112178     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2016.05.030     Document Type: Article

References (39)

1. Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(suppl 5):e278S-e313S.
2. Baltayiannis N, Chandrinos M, Anagnostopoulos D, et al. Lung cancer surgery: an up to date. J Thorac Dis. 2013;5(suppl 4):S425-S439.
3. Zheng X, Schipper M, Kidwell K, et al. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis. Int J Radiat Oncol Biol Phys. 2014;90:603-611.
4. Chang MY, Mentzer SJ, Colson YL, et al. Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007;134:850-856.
5. Haque W, Szeja S, Tann A, Kalra S, Teh BS. Changes in treatment patterns and overall survival in patients with early-stage non-small cell lung cancer in the United States after the incorporation of stereotactic ablative radiation therapy: a population-based analysis [e-pub ahead of print]. Am J Clin Oncol. 2016. http:// dx.doi.org/10.1097/COC.0000000000000265, accessed February 11, 2016.
6. Dosoretz DE, Katin MJ, Blitzer PH, et al. Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys. 1992;24:3-9.
7. Sibley GS, Jamieson TA, Marks LB, Anscher MS, Prosnitz LR. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys. 1998;40:149-154.
8. Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 2007;132:193-199.
9. O'Keefe EB, Meltzer JP, Bethea TN. Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000-2010. Front Public Health. 2015;3:51.
10. Zeng C, Wen W, Morgans AK, Pao W, Shu XO, Zheng W. Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program in the United States, 1990 to 2010. JAMA Oncol. 2015;1:88-96.
11. Coughlin SS, Matthews-Juarez P, Juarez PD, Melton CE, King M. Opportunities to address lung cancer disparities among African Americans. Cancer Med. 2014;3:1467-1476.
12. Hardy D, Liu CC, Xia R, et al. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Cancer. 2009;115:2199-2211.
13. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341:1198-1205.
14. Hardy D, Xia R, Liu CC, Cormier JN, Nurgalieva Z, Du XL. Racial disparities and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients. Cancer. 2009;115:4807-4818.
15. Bryant AS, Cerfolio RJ. Impact of race on outcomes of patients with non-small cell lung cancer. J Thorac Oncol. 2008;3:711-715.
16. Koshy M, Malik R, Spiotto M, Mahmood U, Weichselbaum R, Sher D. Disparities in treatment of patients with inoperable stage I non-small cell lung cancer: a population-based analysis. J Thorac Oncol. 2015;10:264-271.
17. Khanal Y, Eaton J, Pakish J, et al. Survival disparities in non-small cell lung cancer patients receiving radiation treatment: an investigation of race and gender. J Cancer Res Exp Oncol. 2010;2:29-34.
18. Lathan CS, Neville BA, Earle CC. The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol. 2006;24:413-418.
19. Zullig LL, Jackson GL, Dorn RA, et al. Cancer incidence among patients of the U.S. Veterans Affairs Health Care System. Mil Med. 2012;177:693-701.
20. Ganti AK, Subbiah SP, Kessinger A, Gonsalves WI, Silberstein PT, Loberiza FR Jr. Association between race and survival of patients with non-small-cell lung cancer in the United States veterans affairs population. Clin Lung Cancer. 2014;15:152-158.
21. Kim AW, Detterbeck FC, Boffa DJ, et al. Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of earlystage lung cancer. Ann Thorac Surg. 2012;94:895-901.
22. Billmeier SE, Ayanian JZ, Zaslavsky AM, Nerenz DR, Jaklitsch MT, Rogers SO. Predictors and outcomes of limited resection for early-stage non-small cell lung cancer. J Natl Cancer Inst. 2011;103:1621-1629.
23. Osarogiagbon RU, D'Amico TA. Improving lung cancer outcomes by improving the quality of surgical care. Transl Lung Cancer Res. 2015;4:424-431.
24. Powell HA, Tata LJ, Baldwin DR, Stanley RA, Khakwani A, Hubbard RB. Early mortality after surgical resection for lung cancer: an analysis of the English National Lung Cancer Audit. Thorax. 2013;68:826-834.
25. Hu Y, McMurry TL, Wells KM, Isbell JM, Stukenborg GJ, Kozower BD. Postoperative mortality is an inadequate quality indicator for lung cancer resection. Ann Thorac Surg. 2014;97:973-979; discussion 978-979.
26. St Julien JB, Pinkerman R, Aldrich MC, et al. Poor survival for veterans with pathologic stage I non-small-cell lung cancer. Am J Surg. 2012;204:637-642.
27. Corso CD, Park HS, Kim AW, Yu JB, Husain Z, Decker RH. Racial disparities in the use of SBRT for treating earlystage lung cancer. Lung Cancer. 2015;89:133-138.
28. Brzezniak C, Satram-Hoang S, Goertz HP, et al. Survival and Racial Differences of Non-Small Cell Lung Cancer in the United States Military. J Gen Intern Med. 2015;30:1406-1412.
29. Shirvani SM, Jiang J, Chang JY, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys. 2012;84:1060-1070.
30. Farjah F, Wood DE, Yanez ND 3rd, et al. Racial disparities among patients with lung cancer who were recommended operative therapy. Arch Surg. 2009;144:14-18.
31. Zheng L, Enewold L, Zahm SH, et al. Lung cancer survival among black and white patients in an equal access health system. Cancer Epidemiol Biomarkers Prev. 2012;21:1841-1847.
32. Jeppesen SS, Schytte T, Jensen HR, Brink C, Hansen O. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates. Acta Oncol. 2013;52:1552-1558.
33. Tannenbaum SL, Koru-Sengul T, Zhao W, Miao F, Byrne MM. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status. Cancer J. 2014;20:237-245.
34. Ogle KS, Swanson GM, Woods N, Azzouz F. Cancer and comorbidity: redefining chronic diseases. Cancer. 2000;88:653-663.
35. Williams CD, Stechuchak KM, Zullig LL, Provenzale D, Kelley MJ. Influence of comorbidity on racial differences in receipt of surgery among US veterans with earlystage non-small-cell lung cancer. J Clin Oncol. 2013;31:475-481.
36. Kupersmith J, LaBarca D. Using comparative effectiveness research to remedy health disparities. J Comp Eff Res. 2014;3:177-184.
37. Oddone EZ, Olsen MK, Lindquist JH, et al. Enrollment in clinical trials according to patients race: experience from the VA Cooperative Studies Program (1975-2000). Control Clin Trials. 2004;25:378-387.
38. Aberle DR, Adams AM, Berg CD, et al. Reduced lungcancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409.
39. Valle LF, Jagsi R, Bobiak SN, et al. Variation in definitive therapy for localized non-small cell lung cancer among National Comprehensive Cancer Network institutions. Int J Radiat Oncol Biol Phys. 2016;94:360-367.